These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7831419)

  • 1. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine.
    Wadenberg ML; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 1993; 110(3):273-9. PubMed ID: 7831419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
    Swerdlow NR; Keith VA; Braff DL; Geyer MA
    J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade.
    Didriksen M; Olsen GM; Christensen AV
    Psychopharmacology (Berl); 1993; 113(2):250-6. PubMed ID: 7855190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in escape-avoidance response in mice after acute administration of raclopride, clozapine, and SCH 23390.
    Monleón S; Vinader-Caerols C; Parra A
    Pharmacol Biochem Behav; 1998 Jun; 60(2):489-97. PubMed ID: 9632232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P; Karlsson T; Ahlenius S
    Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice.
    Aguilar MA; Marí-Sanmillán MI; Morant-Deusa JJ; Miñarro J
    Behav Neurosci; 2000 Apr; 114(2):389-400. PubMed ID: 10832799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat.
    Ahlenius S; Wijkström A
    Eur J Pharmacol; 1992 Nov; 222(1):69-74. PubMed ID: 1361441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptics and dopamine transporters.
    Reader TA; Ase AR; Huang N; Hébert C; van Gelder NM
    Neurochem Res; 1998 Jan; 23(1):73-80. PubMed ID: 9482270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists.
    Fowler SC; Liou JR
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):24-30. PubMed ID: 7862901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI; Florijn WJ; Creese I
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.
    Ninan I; Wang RY
    Eur J Neurosci; 2003 Mar; 17(6):1306-12. PubMed ID: 12670320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
    McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
    Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.